<DOC>
	<DOCNO>NCT00379990</DOCNO>
	<brief_summary>This exploratory study examine effect iNOS inhibition rheumatoid arthritis patient . The study involve 28 day repeat dose GW274150 ( dose determine result previous study ) , prednisolone ( 7.5mg ) placebo .</brief_summary>
	<brief_title>A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion criterion : Diagnosis rheumatoid arthritis accord revised 1987 criterion American College Rheumatology Female subject capable become pregnant Active disease define Disease Activity Score ( DAS ) 28 = 4.0 least one metacarpalphalangeal finger ( MCP ) joint either detectable vascularity thickness Stable dos disease modify antirheumatic drug ( DMARDs ) , ( include restrict methotrexate , sulphasalazine hydroxychloroquine combination ) 8 week prior enrollment Patients receive methotrexate must stable folate supplement Must stable dos 2 week prior screen use COX inhibitor Signed consent form The patient able understand comply protocol requirement , instruction protocolstated restriction Exclusion criterion : The subject use , use , oral glucocorticoid within 8 week enrollment The subject currently receive antirheumatic biological therapy ( e.g . infliximab , adalimumab , etanercept anakinra ) The subject receive final dose infliximab adalimumab within 3 month enrollment The subject receive final dose etanercept anakinra within 1 month enrollment The subject receive another investigational drug within 30 day The subject drink 28 unit ( male ) 21 unit ( female ) alcohol week History liver renal disease 6 month prior screen The subject history drug allergy Subject positive Hepatitis B C HIV virus The subject positive pregnancy test The subject positive test drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>iNOS</keyword>
	<keyword>Exhaled NO</keyword>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>